MedPath

SAFEWALKER Contribution to the Rehabilitation of Older People After a Post-fall Syndrome

Not Applicable
Completed
Conditions
Post-fall Syndrome
Interventions
Device: SAFEWALKER
Registration Number
NCT02485171
Lead Sponsor
University Hospital, Toulouse
Brief Summary

The main objective of this study is to evaluate the feasibility and acceptability of the use of the robot "SAFEWALKER" complement classical rehabilitation in a group of elderly patients over 70 years during the rehabilitation of post-fall syndrome.

Detailed Description

The post-fall syndrome is an acute functional complications of falls that affects nearly one in five elderly fallers. It combines phobia of the previous vacuum, axial and hypertension astasia abasia.

Unrecognized and untreated, it progresses to a major regressive syndrome, severe physical, psychological and social implications. Only an early rehabilitation for an early resumption of walking, prevents such a development.

The main element is to support and encourage the subject to walking. In practice, it was found that the physiotherapist can not be present daily and the duration of its intervention is often short-lived.

This study will examine the contribution of a medical device of a walking aid (SAFEWALKER the robot) in the rehabilitation and empowerment of seniors with a post-fall syndrome. The SAFEWALKER, which is a walking aid device (http://www.safewalker.com), completes the support action exercised by a third person, by reducing support and securing travel. It allows the subject to move alone at will and is a continuity in relation to the management of the physiotherapist, a potential source of motivation.

The hypothesis is that the SAFEWALKER device can be complementary to the walking rehabilitation in post-fall syndrome.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients hospitalized for the treatment of post-fall syndrome
Exclusion Criteria
  • Demential pathology (Mini Mental State <20)
  • Parkinson's disease and other degenerative neurological disorders
  • Stroke sequelae
  • Fractures members in the previous 12 months
  • Lower limb prostheses in place within 6 months prior
  • Psychiatric disease
  • Presence of mucocutaneous lesions perineal
  • Obesity (weight >120 kg)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExperimentalSAFEWALKERIntroduction of a walking aid device SAFEWALKER for elderly patients during rehabilitation after a post-fall syndrome.
Primary Outcome Measures
NameTimeMethod
Acceptability of SafewalkerDay 14

A composite measure based on questionnaires assessing the acceptability (patient and therapist).

Feasibility of SafewalkerDay 14

Number of steps performed at each of the rehabilitation sessions A composite measure based on questionnaires assessing the feasibility (patient and therapist).

Secondary Outcome Measures
NameTimeMethod
Step lengthDay 14

This parameter will be collected by a pedometer (manual and electronic) and embedded soles (Dynafoot ®) and motion sensors (Bioval ®).

Quality of lifeDay 14

Using the Short Form 36 scale

Number of falls during the studyDay 14

The nurse will report the number of times that the patient fell during his hospitalization

Independence in basic activities of daily livingDay 14

Using the Activities of Daily Living scale

The fear of fallingDay 14

Using the Falls Efficacy Scale International

Walking speedDay 14

This parameter will be collected by a pedometer (manual and electronic) and embedded soles (Dynafoot ®) and motion sensors (Bioval ®).

Retropulsion degreeDay 14

This parameter will be collected by a pedometer (manual and electronic) and embedded soles (Dynafoot ®) and motion sensors (Bioval ®).

Trial Locations

Locations (1)

Nourhashemi Fatemeh

🇫🇷

Toulouse, MIDI Pyrenees, France

© Copyright 2025. All Rights Reserved by MedPath